Skip to content

A trial comparing how the body absorbs and gets rid of petadeferitrin taken as two different forms in healthy people

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-525025-12-00
Enrollment
18
Registered
2026-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron overload from thalassemia, transfusion-dependent myelodysplastic syndromea and haemolysis

Interventions

None listed

Sponsors

Pharmacosmos A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Apr 8, 2026